RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Health and economic impact of a novel 3-antigen vaccine for the prevention of hepatitis b in adults in Germany
A cost-effectiveness analysis
Talbird, S., Graham, J., Anderson, S., Nossov, M., Beattie, N., Laíns sousa, C., Rak, A., Masters, H., & Diaz-Mitoma, F. (2022). Health and economic impact of a novel 3-antigen vaccine for the prevention of hepatitis b in adults in Germany: A cost-effectiveness analysis. Value in Health, 25(12), S135. https://doi.org/10.1016/j.jval.2022.09.649